Filing Details

Accession Number:
0000899140-25-000547
Form Type:
13G Filing
Publication Date:
2025-04-10 20:00:00
Filed By:
Suvretta Capital Management
Company:
Dbv Technologies S.a. (NASDAQ:DBVT)
Filing Date:
2025-04-11
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
SUVRETTA CAPITAL MANAGEMENT, LLC 0 15,176,015 9.9%
Aaron Cowen 0 15,176,015 9.9%
Averill Master Fund, Ltd. 0 13,385,351 8.81%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Note in relation to Items 9 and 11: Includes (i) 210,221 Ordinary Shares (as defined below) and (ii) 14,965,794 Ordinary Shares issuable upon exercise of certain pre-funded warrants of the Issuer after giving effect to the Beneficial Ownership Limitation (as defined below). The warrants are subject to a blocker which prevents the holder from exercising the warrants to the extent that, upon such exercise, the holder, together with its affiliates, would beneficially own in excess of 9.99% of the Shares outstanding as a result of the exercise (the "Beneficial Ownership Limitation"). Without giving effect to the Beneficial Ownership Limitation, such Reporting Person (as defined below) would beneficially own 56,822,964 Ordinary Shares, which represents (i) 210,221 Ordinary Shares, (ii) 20,586,452 Ordinary Shares issuable upon the exercise of the first pre-funded warrants and (iii) 36,026,291 Ordinary Shares issuable upon the exercise of the second pre-funded warrants, which warrants are issuable upon the exercise of certain warrants currently held by the Reporting Person. Note in relation to Item 11: Based on 151,912,061 Ordinary Shares outstanding, which represents (i) 136,946,267 Ordinary Shares outstanding as of March 27, 2025, as indicated by the Issuer on March 27, 2025, plus (ii) 14,965,794 Ordinary Shares issuable upon exercise of the warrants after giving effect to the Beneficial Ownership Limitation.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note in relation to Items 9 and 11: Includes (i) 210,221 Ordinary Shares and (ii) 14,965,794 Ordinary Shares issuable upon exercise of certain pre-funded warrants of the Issuer after giving effect to the Beneficial Ownership Limitation. Without giving effect to the Beneficial Ownership Limitation, such Reporting Person would beneficially own 56,822,964 Ordinary Shares, which represents (i) 210,221 Ordinary Shares, (ii) 20,586,452 Ordinary Shares issuable upon the exercise of the first pre-funded warrants and (iii) 36,026,291 Ordinary Shares issuable upon the exercise of the second pre-funded warrants, which warrants are issuable upon the exercise of certain warrants currently held by the Reporting Person. Note in relation to Item 11: Based on 151,912,061 Ordinary Shares outstanding, which represents (i) 136,946,267 Ordinary Shares outstanding as of March 27, 2025, as indicated by the Issuer on March 27, 2025, plus (ii) 14,965,794 Ordinary Shares issuable upon exercise of the warrants after giving effect to the Beneficial Ownership Limitation.


SCHEDULE 13G



Comment for Type of Reporting Person:  Note in relation to Items 9 and 11: Includes (i) 185,520 Ordinary Shares and (ii) 13,199,831 Ordinary Shares issuable upon exercise of certain pre-funded warrants of the Issuer after giving effect to the Beneficial Ownership Limitation. Without giving effect to the Beneficial Ownership Limitation, such Reporting Person would beneficially own 50,177,963 Ordinary Shares, which represents (i) 185,520 Ordinary Shares, (ii) 18,157,252 Ordinary Shares issuable upon the exercise of the first pre-funded warrants and (iii) 31,775,191 Ordinary Shares issuable upon the exercise of the second pre-funded warrants, which warrants are issuable upon the exercise of certain warrants currently held by the Reporting Person. Note in relation to Item 11: Based on 151,912,061 Ordinary Shares outstanding, which represents (i) 136,946,267 Ordinary Shares outstanding as of March 27, 2025, as indicated by the Issuer on March 27, 2025, plus (ii) 14,965,794 Ordinary Shares upon exercise of the warrants after giving effect to the Beneficial Ownership Limitation.


SCHEDULE 13G


 
SUVRETTA CAPITAL MANAGEMENT, LLC
 
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson / General Counsel and Chief Compliance Officer
Date:04/11/2025
 
Aaron Cowen
 
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:04/11/2025
 
Averill Master Fund, Ltd.
 
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson / Authorized Signatory
Date:04/11/2025